Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -2,390 | -3,870 | N/A | N/A |
| Other Operating Activity | 0 | -200 | 1,240 | 0 | 0 |
| Operating Cash Flow | $N/A | $-2,590 | $-2,630 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -12,730 | -50,180 | 0 | 0 |
| Investing Cash Flow | $N/A | $-12,730 | $-50,180 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 16,970 | 46,040 | 0 | 0 |
| Financing Cash Flow | $N/A | $16,970 | $46,040 | $N/A | $N/A |
| Beginning Cash Position | N/A | 1,860 | 8,650 | N/A | N/A |
| End Cash Position | N/A | 3,500 | 1,860 | N/A | N/A |
| Net Cash Flow | $N/A | $1,640 | $-6,780 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2,590 | -2,630 | N/A | N/A |
| Free Cash Flow | 0 | -2,590 | -2,630 | 0 | 0 |